“
TL;DR
The central result is the synthesis of evidence showing LNPs as a promising delivery platform to overcome the physicochemical limitations of nutraceuticals.
International Journal of Molecular Sciences · 6 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The central result is the synthesis of evidence showing LNPs as a promising delivery platform to overcome the physicochemical limitations of nutraceuticals.
This narrative review explores lipid nanoparticles (LNPs) as delivery systems for nutraceuticals, including polyphenols, vitamins, and antioxidants, which suffer from poor solubility, stability, and bioavailability. Central findings indicate that LNPs can shield bioactive compounds, improve pharmacokinetic parameters, and reduce toxicity risks. Limitations include the need for more in vivo and clinical studies to fully validate the in vitro and theoretical advantages.